Mind Body Intervention for Chronic Migraine Headaches

Description

The goal of this exploratory study is to test a mind-body interventional approach for the treatment of chronic migraines. The main goal is to obtain feasibility information on the protocol which has been used in other similar conditions. We will also evaluate multiple measurement tools in order to optimize a follow-up pilot study evaluating the impact of the protocol on migraines.

Conditions

Migraines, Chronic Pain

Study Overview

Study Details

Study overview

The goal of this exploratory study is to test a mind-body interventional approach for the treatment of chronic migraines. The main goal is to obtain feasibility information on the protocol which has been used in other similar conditions. We will also evaluate multiple measurement tools in order to optimize a follow-up pilot study evaluating the impact of the protocol on migraines.

Mind Body Intervention for Chronic Migraine Headaches

Mind Body Intervention for Chronic Migraine Headaches

Condition
Migraines
Intervention / Treatment

-

Contacts and Locations

Boston

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States, 02115

Boston

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States, 02115

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Adult (≥ 18 years of age)
  • 2. Previously diagnosed with migraine headache based on ICHD-3 beta criteria 91
  • 3. A score of ≥ 50 on the Headache Impact Test-6 self-report survey (moderate impact) 92
  • 4. Presence of migraine headaches at least 5 days per month
  • 5. Willing to engage in a Mind-Body intervention
  • 6. Willing/able to participate in remote sessions
  • 1. Known history or suspicion of headaches due to organic cause (e.g. cancer, sinus infection, head trauma, cerebrovascular disease)
  • 2. Diagnosis of other chronic pain syndromes that may cloud assessments (e.g. fibromyalgia, chronic idiopathic neck pain)
  • 3. Diagnosis of cognitive impairment or dementia
  • 4. Active addiction disorder, e.g. cocaine or IV heroin use, that would interfere with study participation
  • 5. Major psychiatric comorbidity (e.g., schizophrenia). Anxiety and mild-moderate depression are not considered exclusions.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Beth Israel Deaconess Medical Center,

Michael Donnino, MD, PRINCIPAL_INVESTIGATOR, Beth Israel Deaconess Medical Center

Study Record Dates

2026-11